Ferrous chelator 2,2'-dipyridyl attenuates cerebral vasospasm after experimental subarachnoid haemorrhage in rabbits

J Int Med Res. 2010 Mar-Apr;38(2):583-92. doi: 10.1177/147323001003800220.

Abstract

The effect of 2,2'-dipyridyl (DP) on cerebral vasospasm was investigated in a double-injection rabbit model of subarachnoid haemorrhage (SAH). Thirty-six animals were divided between four groups: control (sham-operated), SAH (model alone), SAH + DP (the SAH model in which DP dissolved in dimethyl sulphoxide [DMSO] was injected once daily for 5 days into the cisterna magna), and SAH + DMSO (the SAH model in which DMSO [vehicle] was injected daily for 5 days). There were significant differences in the basilar artery luminal area, wall thickness, neurological deficit score and vasospasm index between the SAH + DP and SAH groups. There was a significant negative correlation between arterial luminal area and arterial wall thickness, and also between the neurological deficit score and vasospasm index. Cells that were positive for terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labelling (TUNEL) and p53 expression were significantly increased in the SAH + DMSO and SAH groups, but not in the SAH + DP group, versus controls. Thus, DP may attenuate cerebral vasospasm after SAH by suppressing p53-induced apoptosis in the cerebral vessels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,2'-Dipyridyl / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Blotting, Western
  • Chelating Agents / pharmacology*
  • Disease Models, Animal*
  • Immunoblotting
  • Immunoenzyme Techniques
  • Male
  • Rabbits
  • Subarachnoid Hemorrhage / drug therapy*
  • Tumor Suppressor Protein p53 / metabolism
  • Vasospasm, Intracranial / prevention & control*

Substances

  • Chelating Agents
  • Tumor Suppressor Protein p53
  • 2,2'-Dipyridyl